GAPDH and cancer: This last effect has been investigated both in vitro, using as a model a bacterial TST enzyme, which is characterized by the presence of only one cysteine present in the catalytic site, and in vivo, using cancer cells, evaluating the expression of the glycolytic enzyme, glyceraldehyde 3-phosphate dehydrogenase (GAPDH).